Pfizer reaches agreement with YaoPharma for an anti-obesity pill
Pfizer CEO Albert Bourla speaks during a press conference with European Commission President Ursula von der Leyen after a visit…
Biotechnology and pharmaceuticals
Zealand Pharma unveils 2030 plan as weight loss competition heats up
Celsopupo | Stock | fake images Zealand Pharma outlined an ambitious five-year strategy for its anti-obesity portfolio on Thursday, highlighting…
FDA May Add Stricter Safety Warning to Covid Shots
A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing the latest healthcare news directly to your…
Eli Lilly's weight-loss drug retatrutide clears first late-stage study
The Eli Lilly logo appears at the company's office in San Diego, California, USA, on November 21, 2025. Mike Blake…
A biotech stock for investors who fear investing in the risky industry
Citigroup believes investors should consider Ligand Pharmaceuticals for a more conservative bet on the biotech industry. The bank initiated the…
Eli Lilly to build $6 billion manufacturing plant in Alabama
Eli Lilly CEO David A. Ricks speaks at a news conference at Generation Park in Houston, Monday, Sept. 23, 2025.…
RFK Jr. Vaccine Panel Postpones Vote on Infant Hepatitis B Vaccine
Health and Human Services Secretary Robert F. Kennedy Jr.'s hand-picked vaccine committee on Thursday postponed crucial votes on hepatitis B…
Eli Lilly cuts cash prices on vials of weight-loss drug Zepbound
The Eli Lilly logo appears at the company's office in San Diego, California, USA, on November 21, 2025. Mike Blake…
Access to abortion pill mifepristone holds steady under Trump, FDA review looms
Mifepristone and misoprostol pills are shown on Wednesday, Oct. 3, 2018, in Skokie, Illinois. Erin Hooley | Chicago Tribune |…
Eli Lilly reaches $1 trillion market value, first for a healthcare company
A sign with the company's logo sits outside Eli Lilly's headquarters in Indianapolis, Indiana, on March 17, 2024. Scott Olson…